SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Neogen Corp – ‘8-K’ for 3/2/21

On:  Tuesday, 3/2/21, at 5:18pm ET   ·   For:  3/2/21   ·   Accession #:  1193125-21-65747   ·   File #:  0-17988

Previous ‘8-K’:  ‘8-K’ on 1/7/21 for 1/4/21   ·   Next & Latest:  ‘8-K’ on / for 3/23/21

Magnifying glass tilted right emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/02/21  Neogen Corp                       8-K:5,9     3/02/21   11:133K                                   Donnelley … Solutions/FA

Current Report   —   Form 8-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     25K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML      9K 
 7: R1          Document and Entity Information                     HTML     42K 
 9: XML         IDEA XML File -- Filing Summary                      XML     11K 
 6: XML         XBRL Instance -- d114694d8k_htm                      XML     12K 
 8: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 4: EX-101.LAB  XBRL Labels -- neog-20210302_lab                     XML     47K 
 5: EX-101.PRE  XBRL Presentations -- neog-20210302_pre              XML     30K 
 3: EX-101.SCH  XBRL Schema -- neog-20210302                         XSD     12K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               10±    17K 
11: ZIP         XBRL Zipped Folder -- 0001193125-21-065747-xbrl      Zip     10K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX: 
  8-K  
 i NEOGEN CORP  i false  i 0000711377 0000711377 2021-03-02 2021-03-02

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM  i 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)  i March 2, 2021

 

 

NEOGEN CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

 i Michigan    i 0-17988    i 38-2367843

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

 i 620 Lesher Place  i Lansing,  i Michigan    i 48912
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code  i 517- i 372-9200

(Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

 i 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 i 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 i 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 i 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

  N/A  

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company   i 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 


Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Neogen Corporation announced today that G. Bruce Papesh has retired from Neogen’s Board of Directors.

Papesh joined Neogen’s Board in October 1993, and helped guide the company from approximately $8 million in annual revenues to approximately $418 million in revenues in its most recently completed fiscal year (May 31).

From 1987 to 2020, Papesh served as president of Dart, Papesh & Company, Inc., which until 2019 was a SIPC and FINRA member and an investment consulting and financial services firm.

With Papesh’s retirement, Neogen’s Board now consists of: Borel, John Adent, Dr. William Boehm, Dr. Ronald Green, James Tobin, Ralph Rodriguez, Darci Vetter, and Dr. Catherine Woteki.

 

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits

 

99.1    Press Release dated March 2, 2021
104    Cover Page Interactive Data File (embedded within the Inline XBRL document).


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

      NEOGEN CORPORATION
      (Registrant)
Date: March 2, 2021      
     

/s/ Steven J. Quinlan

      Steven J. Quinlan
      Vice President & CFO

Dates Referenced Herein

This ‘8-K’ Filing    Date    Other Filings
Filed on / For Period end:3/2/21None on these Dates
 List all Filings 
Top
Filing Submission 0001193125-21-065747   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2021 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Apr. 22, 4:28:54.0pm ET